Traders Purchase High Volume of Call Options on Enovix (NASDAQ:ENVX)

Enovix Corporation (NASDAQ:ENVXGet Free Report) saw some unusual options trading activity on Thursday. Traders bought 24,162 call options on the company. This represents an increase of 48% compared to the average volume of 16,356 call options.

More Enovix News

Here are the key news stories impacting Enovix this week:

  • Positive Sentiment: Enovix said it began commercial production of its silicon-anode smart eyewear battery and advanced toward completing smartphone qualification, signaling progress toward new revenue streams. Enovix Reports First Quarter 2026 Results
  • Positive Sentiment: The company beat Q1 earnings and revenue estimates, reporting a smaller-than-expected loss per share and 49.1% year-over-year revenue growth, which suggests improving execution. Enovix Corporation (ENVX) Reports Q1 Loss, Beats Revenue Estimates
  • Neutral Sentiment: Shares saw unusual call option activity, with traders buying more calls than normal, indicating elevated speculative interest in the stock.
  • Neutral Sentiment: Oppenheimer, Benchmark, Craig Hallum, and TD Cowen all lowered price targets, but most kept constructive ratings, suggesting analysts still see upside even as they trimmed expectations.
  • Negative Sentiment: Investor sentiment was pressured by weaker forward guidance and continued losses, with coverage noting that commercialization timing remains a key concern. Enovix sinks as losses widen; commercialization timeline remains in focus
  • Negative Sentiment: Recent earnings coverage highlighted that the stock dropped after the results because the company’s guidance and path to profitable commercialization remain uncertain. Enovix Stock Drops Desite Beating Q1 Estimates: Details

Institutional Trading of Enovix

Several large investors have recently modified their holdings of ENVX. Vanguard Group Inc. grew its position in shares of Enovix by 10.9% in the fourth quarter. Vanguard Group Inc. now owns 17,760,708 shares of the company’s stock valued at $129,831,000 after purchasing an additional 1,747,145 shares during the last quarter. Millennium Management LLC grew its position in shares of Enovix by 1,038.9% in the third quarter. Millennium Management LLC now owns 1,476,879 shares of the company’s stock valued at $14,724,000 after purchasing an additional 1,347,200 shares during the last quarter. Two Sigma Investments LP grew its position in shares of Enovix by 9,197.1% in the third quarter. Two Sigma Investments LP now owns 1,200,997 shares of the company’s stock valued at $11,974,000 after purchasing an additional 1,188,079 shares during the last quarter. Barclays PLC grew its position in shares of Enovix by 263.1% in the fourth quarter. Barclays PLC now owns 1,551,941 shares of the company’s stock valued at $11,345,000 after purchasing an additional 1,124,480 shares during the last quarter. Finally, Electron Capital Partners LLC grew its position in shares of Enovix by 13.8% in the third quarter. Electron Capital Partners LLC now owns 8,038,396 shares of the company’s stock valued at $80,143,000 after purchasing an additional 972,103 shares during the last quarter. 50.92% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of research analysts have commented on ENVX shares. Benchmark dropped their price objective on shares of Enovix from $25.00 to $15.00 and set a “buy” rating on the stock in a research note on Thursday. JPMorgan Chase & Co. lowered shares of Enovix from a “neutral” rating to an “underweight” rating in a research note on Wednesday, May 6th. Canaccord Genuity Group dropped their price target on shares of Enovix from $21.00 to $15.00 and set a “buy” rating on the stock in a research note on Thursday, February 26th. Wells Fargo & Company set a $6.00 price target on shares of Enovix in a research note on Thursday, March 12th. Finally, Craig Hallum dropped their price target on shares of Enovix from $10.00 to $8.00 and set a “buy” rating on the stock in a research note on Thursday. Seven equities research analysts have rated the stock with a Buy rating, one has issued a Hold rating and two have issued a Sell rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $12.64.

Get Our Latest Report on ENVX

Enovix Trading Down 13.6%

Shares of Enovix stock opened at $6.30 on Friday. The firm has a market cap of $1.37 billion, a price-to-earnings ratio of -7.59 and a beta of 2.24. Enovix has a 52-week low of $4.61 and a 52-week high of $16.49. The company’s 50-day simple moving average is $5.80 and its 200-day simple moving average is $7.11. The company has a quick ratio of 8.13, a current ratio of 8.34 and a debt-to-equity ratio of 1.90.

Enovix (NASDAQ:ENVXGet Free Report) last issued its earnings results on Wednesday, May 13th. The company reported ($0.14) earnings per share for the quarter, topping the consensus estimate of ($0.15) by $0.01. Enovix had a negative net margin of 499.64% and a negative return on equity of 63.25%. The company had revenue of $7.60 million for the quarter, compared to analyst estimates of $6.95 million. During the same period in the prior year, the business posted ($0.15) earnings per share. The firm’s revenue for the quarter was up 49.1% compared to the same quarter last year. Enovix has set its Q2 2026 guidance at -0.170–0.130 EPS. As a group, equities research analysts anticipate that Enovix will post -0.81 earnings per share for the current year.

About Enovix

(Get Free Report)

Enovix Corporation (NASDAQ: ENVX) develops and manufactures advanced lithium-ion battery cells with a patented three-dimensional silicon-anode architecture. The company’s core focus is on delivering high energy density, improved safety, and longer cycle life compared to conventional graphite-based cells. Enovix’s technology targets a range of applications, including consumer electronics, wearable devices, electric vehicles and stationary energy storage systems.

Founded in 2011 and headquartered in Fremont, California, Enovix has built pilot production capability and is scaling up manufacturing capacity to meet growing demand.

Read More

Receive News & Ratings for Enovix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enovix and related companies with MarketBeat.com's FREE daily email newsletter.